Emily Fernschild Email

Scientist I . Tangen Biosciences

Current Roles

Employees:
12
Revenue:
$1.9M
About
Tangen Biosciences, Inc. was founded in 2013 and is located in Branford, Connecticut. The company developed the TangenDxâ„¢ platform for fast and accurate detection of targeted DNAs and RNAs directly from specimens by using rotary rapid isothermal nucleic acid detection. The Tangen system consists of the TangenDxâ„¢ disc and the GeneSparkâ„¢ instrument, an automated amplification device. The TangenDxâ„¢ platform, which does not require laboratory facilities, is expected to deliver faster, simpler, more sensitive detection at a lower cost than other commercial technologies. Current tests in development include COVID-19, Candida auris, sepsis causing bacterial panel, antibiotic resistance genes, and a fungal blood panel. The system can process samples from whole blood, sputum, skin swabs, nasopharyngeal swabs, etc. The TangenDx FluA/B, RSV, and SARS-CoV-2 Panel assay planned to be released by the upcoming fall season.
Tangen Biosciences Address
20 Commercial Street Branford, Connecticut
Branford, CT
United States
Tangen Biosciences Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.